「紅麹」原料製品で報告漏れ　小林製薬、また不備

　小林製薬は２６日、「紅麹（べにこうじ）」配合サプリメントの健康被害に関する厚生労働省への報告に漏れがあったと発表した。紅麹原料の供給先のうち、問題のあったサプリと同等量以上の紅麹を摂取する製品の報告を求められていたが、５社で取り扱いがあったにもかかわらず「なし」と報告していた。
　小林製薬によると、５社の製品はいずれもＯＥＭ（相手先ブランドによる生産）で、報告対象外と独自解釈したという。同社は６月にもサプリ摂取との関連が疑われる死亡者を過少報告しており、行政報告や情報開示の不備が目立っている。（2024/07/26-21:48）

Japan's Kobayashi Pharmaceutical Co. said Friday that it has failed to report to the health ministry some products containing its "beni koji" red fermented rice that were supplied to five companies.
   Kobayashi Pharmaceutical supplied the products to the five companies as an original equipment manufacturer. Kobayashi Pharmaceutical said it had thought that such products were not subject to the reporting requested by the ministry.
   The ministry requested the Osaka-based company to report products containing the same or larger amount of beni koji as used in its supplements at the center of its health hazard scandal.
   In June, Kobayashi Pharmaceutical was found to have underreported the number of deaths suspected to be linked to the supplements in question.
   According to the ministry, none of the five companies' products are marketed any longer. The ministry asked Kobayashi Pharmaceutical to report by Wednesday whether there are any beni koji-containing products subject to the reporting other than those of the five companies.